SE312554B - - Google Patents

Info

Publication number
SE312554B
SE312554B SE7677/64A SE767764A SE312554B SE 312554 B SE312554 B SE 312554B SE 7677/64 A SE7677/64 A SE 7677/64A SE 767764 A SE767764 A SE 767764A SE 312554 B SE312554 B SE 312554B
Authority
SE
Sweden
Application number
SE7677/64A
Inventor
A Fuerst
E Herzog
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE312554B publication Critical patent/SE312554B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
SE7677/64A 1963-07-09 1964-06-24 SE312554B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH851363A CH433275A (de) 1963-07-09 1963-07-09 Verfahren zur Herstellung von 19-Alkylsteroiden

Publications (1)

Publication Number Publication Date
SE312554B true SE312554B (de) 1969-07-21

Family

ID=4341402

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7677/64A SE312554B (de) 1963-07-09 1964-06-24

Country Status (10)

Country Link
US (1) US3309387A (de)
BE (1) BE650260A (de)
BR (1) BR6460648D0 (de)
CH (1) CH433275A (de)
DE (1) DE1468035C3 (de)
DK (1) DK115400B (de)
ES (1) ES301833A1 (de)
GB (1) GB1040554A (de)
NL (1) NL6406879A (de)
SE (1) SE312554B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH464189A (de) * 1966-04-20 1968-10-31 Hoffmann La Roche Verfahren zur Herstellung von 19-Alkenylsteroiden
US3859272A (en) * 1968-07-23 1975-01-07 Hoechst Ag 19-alkylene-14- ' -hydroxy-cardenolide derivatives and process for preparing them
US4139617A (en) * 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
WO2005020928A2 (en) * 2003-08-29 2005-03-10 The Regents Of The University Of California Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
WO2005051972A1 (en) * 2003-11-24 2005-06-09 Merck & Co., Inc. Estrogen receptor modulators
AU2005254949A1 (en) * 2004-06-10 2005-12-29 Merck & Co., Inc. Estrogen receptor modulators
CN1976944A (zh) * 2004-06-30 2007-06-06 默克公司 雌激素受体调节剂
CA2643732C (en) * 2006-02-27 2012-08-21 The Regents Of The University Of California Oxysterol compounds and the hedgehog pathway
CN101951915A (zh) * 2007-12-03 2011-01-19 加利福尼亚大学董事会 用于刺猬蛋白信号、骨诱导、抗脂肪形成和wnt信号的激活的氧固醇
CA2872751A1 (en) 2012-05-07 2013-11-14 The Regents Of The University Of California Oxysterol analogue oxy133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis
JP2016517888A (ja) 2013-05-02 2016-06-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 骨選択的骨形成のオキシステロール骨標的薬剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2844603A (en) * 1955-07-05 1958-07-22 Searle & Co Process for oxidation of steroids with peroxytrifluoroacetic acid
NL286295A (de) * 1961-12-04
BE632431A (de) * 1962-05-16
US3102127A (en) * 1962-06-12 1963-08-27 Syntex Corp 19-methylene-androstane derivatives
US3206458A (en) * 1962-06-12 1965-09-14 Syntex Corp 19-substituted pregnenes

Also Published As

Publication number Publication date
CH433275A (de) 1967-04-15
US3309387A (en) 1967-03-14
DK115400B (da) 1969-10-06
ES301833A1 (es) 1962-12-16
DE1468035C3 (de) 1974-03-21
DE1468035A1 (de) 1968-12-12
DE1468035B2 (de) 1973-08-02
NL6406879A (de) 1965-01-11
GB1040554A (en) 1966-09-01
BE650260A (de) 1965-01-08
BR6460648D0 (pt) 1973-12-26

Similar Documents

Publication Publication Date Title
BE627012A (de)
BE645220A (de)
BE644704A (de)
BE645729A (de)
BE645721A (de)
BE645630A (de)
BE645576A (de)
BE650260A (de)
BE644790A (de)
BE644094A (de)
BE643645A (de)
BE643429A (de)
BE643428A (de)
BE643224A (de)
BE643067A (de)
BE642962A (de)
BE624811A (de)
BE642453A (de)
BE642369A (de)
BE640849A (de)
BE636086A (de)
BE633066A (de)
BE628992A (de)
BE627686A (de)
BE627172A (de)